Chetzemoka to Medicine@mander.xyz · 1 year agoTrial of semaglutide ends early based on successful demonstration of efficacy in sustaining kidney function in people with diabetes and kidney diseasewww.reuters.comexternal-linkmessage-square0fedilinkarrow-up143arrow-down10cross-posted to: medicine@mander.xyz
arrow-up143arrow-down1external-linkTrial of semaglutide ends early based on successful demonstration of efficacy in sustaining kidney function in people with diabetes and kidney diseasewww.reuters.comChetzemoka to Medicine@mander.xyz · 1 year agomessage-square0fedilinkcross-posted to: medicine@mander.xyz